Literature DB >> 17287431

Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.

Thomas Quaschning1, Florian Voss, Katharina Relle, Philipp Kalk, Nicolas Vignon-Zellweger, Thiemo Pfab, Christian Bauer, Franziska Theilig, Sebastian Bachmann, Annette Kraemer-Guth, Christoph Wanner, Franz Theuring, Jan Galle, Berthold Hocher.   

Abstract

Endothelin-1 (ET-1) is one of the most potent biologic vasoconstrictors. Nevertheless, transgenic mice that overexpress ET-1 exhibit normal BP. It was hypothesized that vascular effects of ET-1 may be antagonized by an increase of the endothelial counterpart of ET-1, nitric oxide (NO), which is produced by the endothelial NO synthase (eNOS). Therefore, cross-bred animals of ET transgenic mice (ET+/+) and eNOS knockout (eNOS-/-) mice and were generated, and BP and endothelial function were evaluated in these animals. Endothelium-dependent and -independent vascular function was assessed as relaxation/contraction of isolated preconstricted aortic rings. The tissue ET and NO system was determined in aortic rings by quantitative real-time PCR and Western blotting. Systolic BP was similar in ET+/+ and wild-type (WT) mice but was significantly elevated in eNOS-/- mice (117 +/- 4 mmHg versus 94 +/- 6 mmHg in WT mice; P < 0.001) and even more elevated in ET+/+ eNOS-/- cross-bred mice (130 +/- 4 mmHg; P < 0.05 versus eNOS-/-). Maximum endothelium-dependent relaxation was enhanced in ET+/+ mice (103 +/- 6 versus 87 +/- 4% of preconstriction in WT littermates; P < 0.05) and was completely blunted in eNOS-/- (-3 +/- 4%) and ET+/+ eNOS-/- mice (-4 +/- 4%), respectively. Endothelium-independent relaxation was comparable among all groups. Quantitative real-time PCR as well as Western blotting revealed an upregulation of the aortic ET(A) and ET(B) receptors in ET+/+ eNOS-/-, whereas eNOS was absent in aortic rings of eNOS-/- and ET+/+ eNOS-/- mice. ET-1 aortic tissue concentrations were similar in WT mice and ET+/+ eNOS-/- mice most probably as a result of an enhanced clearance of ET-1 by the upregulated ET(B) receptor. These data show for the first time that in transgenic mice that overexpress human ET-1, additional knockout of eNOS results in a further enhancement of BP as compared with eNOS-/- mice. The human ET+/+ eNOS-/- mice therefore represent a novel model of hypertension as a result of an imbalance between the vascular ET-1 and NO systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287431     DOI: 10.1681/ASN.2006050541

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

1.  eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

Authors:  Feng Li; John R Hagaman; Hyung-Suk Kim; Nobuyo Maeda; J Charles Jennette; James E Faber; S Ananth Karumanchi; Oliver Smithies; Nobuyuki Takahashi
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice.

Authors:  Oliver Baretella; Sookja K Chung; Aimin Xu; Paul M Vanhoutte
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

3.  Chronic Elevation of Endothelin-1 Alone May Not Be Sufficient to Impair Endothelium-Dependent Relaxation.

Authors:  Zachary I Grunewald; Thomas J Jurrissen; Makenzie L Woodford; Francisco I Ramirez-Perez; Lauren K Park; Ryan Pettit-Mee; Thaysa Ghiarone; Scott M Brown; Mariana Morales-Quinones; James R Ball; Kevin F Staveley-O'Carroll; Annayya R Aroor; Paul J Fadel; Pierre Paradis; Ernesto L Schiffrin; Shawn B Bender; Luis A Martinez-Lemus; Jaume Padilla
Journal:  Hypertension       Date:  2019-10-21       Impact factor: 10.190

4.  Kynurenine is an endothelium-derived relaxing factor produced during inflammation.

Authors:  Yutang Wang; Hanzhong Liu; Gavin McKenzie; Paul K Witting; Johannes-Peter Stasch; Michael Hahn; Dechaboon Changsirivathanathamrong; Ben J Wu; Helen J Ball; Shane R Thomas; Vimal Kapoor; David S Celermajer; Andrew L Mellor; John F Keaney; Nicholas H Hunt; Roland Stocker
Journal:  Nat Med       Date:  2010-02-28       Impact factor: 53.440

5.  Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.

Authors:  Kristin Schmerbach; Thiemo Pfab; Yi Zhao; Juraj Culman; Susanne Mueller; Arno Villringer; Dominik N Muller; Berthold Hocher; Thomas Unger; Christa Thoene-Reineke
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

6.  Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1.

Authors:  Chad E N Reiter; Jeong-a Kim; Michael J Quon
Journal:  Endocrinology       Date:  2009-11-03       Impact factor: 4.736

7.  Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition.

Authors:  Adelina Stoessel; Alexander Paliege; Franziska Theilig; Francesco Addabbo; Brian Ratliff; Jens Waschke; Daniel Patschan; Michael S Goligorsky; Sebastian Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-02

8.  Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice.

Authors:  Torsten Slowinski; Philipp Kalk; Maren Christian; Fred Schmager; Katharina Relle; Michael Godes; Heiko Funke-Kaiser; Hans-H Neumayer; Christian Bauer; Franz Theuring; Berthold Hocher
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

9.  Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice.

Authors:  Kehuan Luo; Larry G Thaete; Mark G Neerhof
Journal:  Reprod Sci       Date:  2016-01-19       Impact factor: 3.060

Review 10.  An integrated view of insulin resistance and endothelial dysfunction.

Authors:  Ranganath Muniyappa; Micaela Iantorno; Michael J Quon
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.